3,4-Dihydro Naratriptan
3,4-Dihydro Naratriptan is a serotonin 5-HT1-receptor agonist. 3,4-Dihydro Naratriptan exhibits selective vasoconstrictor activity. 3,4-Dihydro Naratriptan can be used for migraine diseases research[1].
Product Specifications
CAS Number
[121679-20-7]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
5-HT Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/3-4-dihydro-naratriptan.html
Solubility
10 mM in DMSO
Smiles
O=S(CCC1=CC2=C(NC=C2C3=CCN(C)CC3)C=C1)(NC)=O
Molecular Formula
C17H23N3O2S
Molecular Weight
333.45
Precautions
H302, H315, H319, H335
References & Citations
[1]Sampath Kumar, U., et al. "An investigation into the formation of impurity b during the optimization of naratriptan hydrochloride." Organic Process Research & Development 13.3 (2009) : 468-470.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
034904-HRP 200 µL
ECHDC1, CT (ECHDC1, Ethylmalonyl-CoA decarboxylase, Enoyl-CoA hydratase domain-containing protein 1, Methylmalonyl-CoA decarboxylase) (Azide free) (HRP) discontinued
Ask
View Details 
GTR15090064 1 Vial
Lentiviral human PCOTH shRNA (UAS) - Lentiviral human PCOTH shRNA (UAS, iRFP) plasmid
Ask
View Details